Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan and Minocycline Dual Therapy for H. pylori
NCT06523764Phase 4Active, not recruiting
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Nov 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tegoprazan in Helicobacter pylori infection, sponsored by Xijing Hospital of Digestive Diseases. Started Nov 2024; status: active, not recruiting.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06523764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06523764.